Log in

TTK Healthcare

NSE: TTKHLTCARE · ISIN INE910C01018 · Healthcare

₹936.60+4.85 (+0.52%)

Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.

Price chart

₹936.60 +4.85 (+0.52%) today

The day

Previous close
₹931.75
Open
₹924.00
Day high
₹938.95
Day low
₹924.00

Listed on NSE since 2 December 2015.

Key numbers

Market value
₹1,323.45 Cr
P/E (trailing)
4.79
EPS (trailing)
₹195.71
Price to book
0.98
Dividend yield
1.07%
Return on equity
22.7%
Debt to equity
0.02
Profit margin
30.1%
Beta
0.40
Volume today
2,695
Average volume
34,277

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹720.19 Cr₹639.71 Cr₹452.72
FY24₹747.64 Cr₹62.84 Cr₹44.47
FY25₹797.63 Cr₹81.66 Cr₹57.79
FY26₹854.38 Cr₹65.68 Cr₹46.48

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹233 Cr₹223 Cr₹157.80+993.7%
Q1 FY27Apr–Jun 2026₹258 Cr₹21 Cr₹15.06+63.7%
Q4 FY26Jan–Mar 2026Audited₹218 Cr₹22 Cr₹15.40+34.8%
Q3 FY26Oct–Dec 2025₹209 Cr₹11 Cr₹7.45–
Q2 FY26Jul–Sep 2025₹204 Cr₹20 Cr₹14.43–
Q1 FY26Apr–Jun 2025₹226 Cr₹13 Cr₹9.20–

Source: TTK Healthcare’s results filed with NSE, standalone (the company alone). Net profit is the share of TTK Healthcare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹66 Cr₹74 Cr₹79 Cr
Investments₹12 Cr₹9 Cr₹12 Cr
Inventories₹113 Cr₹109 Cr₹102 Cr
Owed by customers₹117 Cr₹111 Cr₹112 Cr
Cash and equivalents₹90 Cr₹22 Cr₹13 Cr
Total assets₹1,651 Cr₹1,329 Cr₹1,296 Cr
Borrowings₹26 Cr₹24 Cr₹26 Cr
Total liabilities₹305 Cr₹214 Cr₹210 Cr
Shareholders’ equity₹1,347 Cr₹1,115 Cr₹1,085 Cr

Source: TTK Healthcare’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.

Industry
Drug Manufacturers - General
Based in
Chennai
Employees
1,384

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name TTK Healthcare in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 10 Per Share

    Dividend · ex-date 17 July 2026

  • Annual General Meeting/Dividend - Rs 10 Per Share

    Dividend · ex-date 18 July 2025

  • Annual General Meeting/Dividend - Rs10 Per Sh/

    Dividend · ex-date 16 July 2024

  • Annual General Meeting/Dividend - Rs 10 Per Share

    Dividend · ex-date 18 July 2023

  • Annual General Meeting/Dividend - Rs 10 Per Share

    Dividend · ex-date 26 July 2022

  • Annual General Meeting/Dividend - Rs 6 Per Share

    Dividend · ex-date 12 August 2021

  • Annual General Meeting/Dividend - Rs 3 Per Share

    Dividend · ex-date 3 September 2020

  • Annual General Meeting/Dividend - Rs 5 Per Share

    Dividend · ex-date 1 August 2019

Source: NSE. Latest first, 8 of 11.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.